Retatrutide 10mg
As low as A$240.00/unit
Research Use Only: This product is sold for laboratory and in-vitro research purposes. Not for human consumption or therapeutic use.
Product Details
Health Benefits of Retatrutide 10mg
Triple Receptor Agonist
Retatrutide is a first-in-class triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This tri-agonist approach is unique among incretin-based peptides and has shown unprecedented efficacy in clinical trials for metabolic research.
Significant Weight Loss Research
Phase 2 clinical trials published in the New England Journal of Medicine demonstrated up to 24.2% body weight reduction over 48 weeks — the highest weight loss ever achieved with a single pharmacological agent in clinical trials.
Improved Glycaemic Control
Research shows retatrutide significantly improves HbA1c, fasting glucose, and insulin sensitivity. The combination of GLP-1 and GIP receptor activation provides dual incretin benefit for glucose metabolism research.
Glucagon-Mediated Energy Expenditure
Unlike dual GLP-1/GIP agonists (e.g. tirzepatide), retatrutide's glucagon receptor activation increases energy expenditure, hepatic lipid oxidation, and thermogenesis. This third mechanism contributes to its superior weight loss efficacy in research models.
Liver Fat Reduction
Clinical data suggests retatrutide significantly reduces hepatic fat content, with studies showing potential applications in non-alcoholic fatty liver disease (NAFLD/MASH) research. Glucagon receptor activation directly promotes hepatic fat oxidation.
Cardiovascular Metabolic Benefits
Research demonstrates improvements in cardiovascular risk markers including blood pressure, triglycerides, and inflammatory markers, suggesting broad cardiometabolic benefits beyond weight management.
Note: The health benefits listed above are based on published scientific research and clinical studies. Individual results may vary. This product is sold for research purposes only — not for human consumption. Always consult published literature for detailed study methodologies and findings.
Frequently Asked Questions — Retatrutide 10mg
What is Retatrutide?
Retatrutide (LY3437943) is a novel triple-acting peptide agonist developed by Eli Lilly. It simultaneously activates GLP-1, GIP, and glucagon receptors — making it the first tri-agonist in its class. Phase 2 clinical trials have shown unprecedented efficacy in weight management and metabolic research.
How does Retatrutide compare to Semaglutide and Tirzepatide?
Semaglutide is a GLP-1 receptor agonist (single target). Tirzepatide is a dual GLP-1/GIP agonist (two targets). Retatrutide adds glucagon receptor activation as a third target, increasing energy expenditure and hepatic fat oxidation. Phase 2 trials showed retatrutide achieved greater weight loss (24.2%) than either semaglutide (~15%) or tirzepatide (~22.5%).
What makes the glucagon receptor important?
Glucagon receptor activation increases hepatic glucose output, promotes fat oxidation in the liver, increases energy expenditure, and enhances thermogenesis. These effects complement the appetite-suppressing and insulin-sensitising actions of GLP-1 and GIP, creating a comprehensive metabolic effect.
Can I buy Retatrutide in Australia?
Yes — OzTideLab ships Retatrutide 10mg across Australia via Australia Post. Free standard shipping on orders over A$199. HPLC-verified ≥98% purity, discreet packaging, and PayID/Osko payment accepted.
Research Applications
This peptide is supplied for in-vitro laboratory research only. Common research applications include receptor binding assays, cell culture studies, structure-activity relationship analysis, and bioassay development. Researchers should consult relevant literature for specific experimental protocols.
Storage & Handling
- • Store lyophilised powder at -20°C for long-term stability
- • Short-term storage: 2-8°C (refrigerated)
- • Protect from light, moisture, and repeated freeze-thaw cycles
- • Once reconstituted, use within the recommended timeframe
Purity & HPLC Analysis
Every batch is independently verified via High-Performance Liquid Chromatography (HPLC) to confirm ≥98% purity. Mass spectrometry (MS) is used for molecular identity confirmation. Certificates of Analysis (CoA) are available on request — email [email protected] with your order number.
Reconstitution Guidelines
- • Use bacteriostatic water or sterile water for reconstitution
- • Add solvent slowly along the vial wall — do not shake
- • Gently swirl until fully dissolved (clear solution)
- • Store reconstituted solution at 2-8°C and use within 28 days
- • Use sterile technique throughout to prevent contamination
HPLC Verified
≥98% purity certified
Australian Owned
Local team, local support
Discreet Shipping
Plain packaging AU-wide
Research Grade
Lab-quality peptides
